Citigroup’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-495
| Closed | -$1K | – | 5036 |
|
|
2022
Q3 | $1K | Sell |
495
-13,867
| -97% | -$28K | ﹤0.01% | 4856 |
|
|
2022
Q2 | $11K | Buy |
14,362
+12,781
| +808% | +$9.79K | ﹤0.01% | 4603 |
|
|
2022
Q1 | $14K | Sell |
1,581
-31,323
| -95% | -$277K | ﹤0.01% | 4601 |
|
|
2021
Q4 | $527K | Buy |
32,904
+16,819
| +105% | +$269K | ﹤0.01% | 3013 |
|
|
2021
Q3 | $296K | Sell |
16,085
-23,245
| -59% | -$428K | ﹤0.01% | 3194 |
|
|
2021
Q2 | $549K | Sell |
39,330
-46,618
| -54% | -$651K | ﹤0.01% | 3010 |
|
|
2021
Q1 | $1.27M | Buy |
85,948
+80,845
| +1,584% | +$1.19M | ﹤0.01% | 2216 |
|
|
2020
Q4 | $99K | Buy |
5,103
+3,483
| +215% | +$67.6K | ﹤0.01% | 3681 |
|
|
2020
Q3 | $18K | Sell |
1,620
-1,356
| -46% | -$15.1K | ﹤0.01% | 4025 |
|
|
2020
Q2 | $40K | Sell |
2,976
-1,066
| -26% | -$14.3K | ﹤0.01% | 3880 |
|
|
2020
Q1 | $33K | Buy |
4,042
+1,644
| +69% | +$13.4K | ﹤0.01% | 4096 |
|
|
2019
Q4 | $23K | Buy |
2,398
+1,108
| +86% | +$10.6K | ﹤0.01% | 4445 |
|
|
2019
Q3 | $14K | Sell |
1,290
-1,339
| -51% | -$14.5K | ﹤0.01% | 4438 |
|
|
2019
Q2 | $31K | Buy |
2,629
+625
| +31% | +$7.37K | ﹤0.01% | 4391 |
|
|
2019
Q1 | $25K | Sell |
2,004
-256
| -11% | -$3.19K | ﹤0.01% | 4426 |
|
|
2018
Q4 | $14K | Sell |
2,260
-73
| -3% | -$452 | ﹤0.01% | 4540 |
|
|
2018
Q3 | $24K | Buy |
2,333
+1,018
| +77% | +$10.5K | ﹤0.01% | 4452 |
|
|
2018
Q2 | $19K | Buy |
1,315
+513
| +64% | +$7.41K | ﹤0.01% | 4412 |
|
|
2018
Q1 | $11K | Buy |
802
+121
| +18% | +$1.66K | ﹤0.01% | 4455 |
|
|
2017
Q4 | $8K | Buy |
+681
| New | +$8K | ﹤0.01% | 4566 |
|